Shedir Pharma Group S.p.A.

SHE

IT0005379620

Pharmaceuticals

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-05-30 EDT			5-day change	1st Jan Change
3.94 ^EUR	0.00%		+3.68%	-12.83%

04-02	Shedir Pharma, into 2023 with rising revenues; profit down single digits	AN
03-29	Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Shedir Pharma Group S.P.A. Reports Earnings Results for the Full Year Ended December 31, 2020

March 28, 2021

Shedir Pharma Group S.P.A. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced total revenue was EUR 44.091 million compared to EUR 50.687 million a year ago. Operating income was EUR 5.974 million compared to EUR 5.272 million a year ago. Net income was EUR 3.926 million compared to EUR 2.838 million a year ago.

Latest news about Shedir Pharma Group S.p.A.

Shedir Pharma, into 2023 with rising revenues; profit down single digits	04-02	AN
Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Shedir Pharma increases profit and revenues in the first half by double digits	23-09-29	AN
Shedir Pharma Group S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28	CI
Shedir Pharma has purchased 4,500 of its own ordinary shares	23-05-23	AN
Shedir Pharma's share buybacks continue	23-05-16	AN
Shedir Pharma Group has purchased 7,500 of its own shares	23-05-02	AN
Shedir Pharma's share buybacks continue	23-04-24	AN
Milan up; Chinese bank does not touch rates	23-04-20	AN
Milan rises above 27,900; MPS bullish	23-04-19	AN
Indexes weak; TIM down after network bids	23-04-19	AN
Stock markets down ahead of Eurozone inflation	23-04-19	AN
Flat start expected in Europe, focus on results	23-04-19	AN
Milan pink jersey led by banks	23-04-18	AN
Shedir Pharma revenues rise to double digits in first quarter	23-04-18	AN
Shedir Pharma has purchased 4,000 shares of its own common stock	23-04-18	AN
ITALY GROWTH WINNERS & LOSERS: Shedir Pharma on top; Il Fatto down	23-04-18	AN
Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-12	CI
Shedir Pharma raises dividend after a 2022 closed with growth	23-03-31	AN
Shedir Pharma Group S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-28	CI
Shedir Pharma Group S.p.A. commences an Equity Buyback Plan, under the authorization approved on April 29, 2022.	22-07-10	CI
Shedir Pharma Group S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-28	CI
Shedir Pharma Group S.P.A. Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-28	CI
Certain Shares of Shedir Pharma Group S.p.A. are subject to a Lock-Up Agreement Ending on 24-JUL-2021.	21-07-23	CI
Shedir Pharma Group S.P.A. Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-28	CI

Chart Shedir Pharma Group S.p.A.

Duration

Period

More charts

Company Profile

Shedir Pharma Srl is an Italy-based pharmaceutical company specialized in nutraceuticals, cosmetics and medical devices. The Company markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SHEDIR PHARMA GROUP S.P.A.	-12.83%	48.42M
ELI LILLY AND COMPANY	+39.82%	731B
NOVO NORDISK A/S	+31.34%	586B
JOHNSON & JOHNSON	-7.31%	348B
MERCK & CO., INC.	+14.23%	319B
ABBVIE INC.	+0.86%	273B
ASTRAZENECA PLC	+13.47%	235B
ROCHE HOLDING AG	-6.63%	203B
NOVARTIS AG	+7.49%	202B
AMGEN INC.	+4.51%	159B

Other Pharmaceuticals